Sequivity(TM) RNA Particle Technology from Merck Animal Health

VS Memorandum: Guidelines for Autogenous Biologics – Comments Accepted Until June 8

The Center for Veterinary Biologics (CVB) recently added Draft Document 638 - VS Memorandum: Guidelines for Autogenous Biologics, to its website for a 3-week comment period. The CVB will consider all comments received by June 8, 2020 before finalizing the guidance document. The purpose of this memorandum is to describe the procedures and guidelines for interpretation of the requirements for autogenous biologics under the provisions of title 9, Code of Federal Regulations (9 CFR), sections 113.113, 113.3(b)(8), and the administrative terminology in section 101.2. [Source: USDA APHIS 21 May 2020]